BioNTech SE (BNTX) has a consensus analyst rating of Buy, based on 24 analysts covering the stock. Of those, 20 recommend buying, 4 recommend holding, and 0 recommend selling.
The analyst consensus price target for BNTX is $137.38, representing a +39.6% upside from the current price of $98.41. Price targets range from a low of $113.00 to a high of $155.00.
